These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18725718)

  • 1. The use of microcalorimetry to compare the biological activity of a CAS and a MBR sludge-application to pharmaceutical active compounds.
    Bouju H; Buttiglieri G; Malpei F
    Water Sci Technol; 2008; 58(3):529-35. PubMed ID: 18725718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
    Radjenović J; Petrović M; Barceló D
    Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of sulfonated and other micropollutants removal in membrane bioreactor and conventional wastewater treatment.
    De Wever H; Weiss S; Reemtsma T; Vereecken J; Müller J; Knepper T; Rörden O; Gonzalez S; Barcelo D; Dolores Hernando M
    Water Res; 2007 Feb; 41(4):935-45. PubMed ID: 17207834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of a broad range of surfactants from municipal wastewater--comparison between membrane bioreactor and conventional activated sludge treatment.
    González S; Petrovic M; Barceló D
    Chemosphere; 2007 Feb; 67(2):335-43. PubMed ID: 17123581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of linear alkylbenzene sulfonates removal in conventional activated sludge systems and membrane bioreactors.
    De Wever H; Van Roy S; Dotremont C; Miller J; Knepper T
    Water Sci Technol; 2004; 50(5):219-25. PubMed ID: 15497851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal of pharmaceutically active compounds in nitrifying-denitrifying plants.
    Suárez S; Ramil M; Omil F; Lema JM
    Water Sci Technol; 2005; 52(8):9-14. PubMed ID: 16312946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adsorption and removal at low atrazine concentration in an MBR pilot plant.
    Buttiglieri G; Migliorisi L; Malpei F
    Water Sci Technol; 2011; 63(7):1334-40. PubMed ID: 21508534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the behaviour of selected micropollutants in a membrane bioreactor and a conventional wastewater treatment plant.
    Clara M; Strenn B; Ausserleitner M; Kreuzinger N
    Water Sci Technol; 2004; 50(5):29-36. PubMed ID: 15497826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Removal of pharmaceuticals and fragrances in biological wastewater treatment.
    Joss A; Keller E; Alder AC; Göbel A; McArdell CS; Ternes T; Siegrist H
    Water Res; 2005 Sep; 39(14):3139-52. PubMed ID: 16043210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of a landfill leachate containing compounds of pharmaceutical origin.
    Matosić M; Terzić S; Korajlija Jakopović H; Mijatović I; Ahel M
    Water Sci Technol; 2008; 58(3):597-602. PubMed ID: 18725727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seasonal variation in the occurrence and removal of pharmaceuticals and personal care products in different biological wastewater treatment processes.
    Sui Q; Huang J; Deng S; Chen W; Yu G
    Environ Sci Technol; 2011 Apr; 45(8):3341-8. PubMed ID: 21428396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel application of TPAD-MBR system to the pilot treatment of chemical synthesis-based pharmaceutical wastewater.
    Chen Z; Ren N; Wang A; Zhang ZP; Shi Y
    Water Res; 2008 Jul; 42(13):3385-92. PubMed ID: 18538367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The characteristics of enriched nitrifier culture in the degradation of selected pharmaceutically active compounds.
    Tran NH; Urase T; Kusakabe O
    J Hazard Mater; 2009 Nov; 171(1-3):1051-7. PubMed ID: 19615816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behaviour of pharmaceuticals and personal care products in a sewage treatment plant of northwest Spain.
    Carballa M; Omil F; Lema JM; Llompart M; García C; Rodriguez I; Gómez M; Ternes T
    Water Sci Technol; 2005; 52(8):29-35. PubMed ID: 16312948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorption and degradation of bisphenol A by aerobic activated sludge.
    Zhao J; Li Y; Zhang C; Zeng Q; Zhou Q
    J Hazard Mater; 2008 Jun; 155(1-2):305-11. PubMed ID: 18179868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradation kinetic constants and sorption coefficients of micropollutants in membrane bioreactors.
    Fernandez-Fontaina E; Pinho I; Carballa M; Omil F; Lema JM
    Biodegradation; 2013 Apr; 24(2):165-77. PubMed ID: 22773131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fate of hazardous aromatic substances in membrane bioreactors.
    Mozo I; Stricot M; Lesage N; Spérandio M
    Water Res; 2011 Oct; 45(15):4551-61. PubMed ID: 21733542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of selected pharmaceuticals by biosolids from municipal wastewater treatment plants: importance of modest pH change and degree of mineralization.
    Kimura K; Hara H; Watanabe Y
    Water Sci Technol; 2010; 62(5):1084-9. PubMed ID: 20818049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active heterotrophic biomass and sludge retention time (SRT) as determining factors for biodegradation kinetics of pharmaceuticals in activated sludge.
    Majewsky M; Gallé T; Yargeau V; Fischer K
    Bioresour Technol; 2011 Aug; 102(16):7415-21. PubMed ID: 21652206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme.
    Joss A; Zabczynski S; Göbel A; Hoffmann B; Löffler D; McArdell CS; Ternes TA; Thomsen A; Siegrist H
    Water Res; 2006 May; 40(8):1686-96. PubMed ID: 16620900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.